Michael P. Curry

Associate Professor of Medicine
Medicine
Beth Israel Deaconess Medical Center
United States of America

Academician Gastroenterology
Biography

Michael P. Curry, M.D., is an Associate Professor of Medicine at Harvard Medical School; the Section Chief of Hepatology, and the Director of the Liver Transplantation at Beth Israel Deaconess Medical Center in Boston. He went to medical school at National University of Ireland, Galway and completed his residency at Roscommon County Hospital and National University of Ireland, Galway, with a fellowship at St. Vincent's Hospital and Beth Israel Deaconess Medical Center.

Research Intrest

Abnormal liver function tests; Alpha-1- antutrypsin; Autoimmune hepatitis; Autoimmune liver disease; Chronic liver disease; Cirrhosis; Cyanoacrylate Glue Injection for Varices; Hemochromatosis; Hepatitis B virus (HBV); Hepatitis C virus (HCV)

List of Publications
Lim J, Curry MP, Sundaram V. Risk factors and outcomes associated with alcohol relapse after liver transplantation. World Journal of Hepatology. 2017 Jun 18;9(17):771.
Sarwar A, Zhou L, Novack V, Tapper EB, Curry M, Malik R, Ahmed M. Hospital volume and mortality after trans‐jugular intrahepatic portosystemic shunt creation in the United States. Hepatology. 2017 Jul 6.
Curry MP, Tapper EB, Bacon B, Dieterich D, Flamm SL, Guest L, Kowdley KV, Lee Y, Milligan S, Tsai N, Younossi Z. Effectiveness of 8‐or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients. Alimentary Pharmacology & Therapeutics. 2017 Sep 1;46(5):540-8.